Somewhat Positive Press Coverage Somewhat Unlikely to Affect Metlife (MET) Share Price

News stories about Metlife (NYSE:MET) have trended somewhat positive recently, Accern Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Metlife earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 46.443166798263 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

Shares of Metlife (MET) traded down $0.35 during mid-day trading on Thursday, hitting $52.49. 4,281,579 shares of the company traded hands, compared to its average volume of 5,689,549. The company has a market cap of $56,476.88, a P/E ratio of 10.32, a price-to-earnings-growth ratio of 1.35 and a beta of 1.49. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.31. Metlife has a 1-year low of $44.26 and a 1-year high of $55.91.

Metlife (NYSE:MET) last announced its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, topping the consensus estimate of $0.90 by $0.19. The business had revenue of $16.10 billion during the quarter, compared to the consensus estimate of $15.47 billion. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. Metlife’s revenue was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.28 EPS. equities research analysts anticipate that Metlife will post 4.43 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 13th. Investors of record on Monday, November 6th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 3.05%. The ex-dividend date of this dividend was Friday, November 3rd. Metlife’s payout ratio is -320.00%.

Several research analysts have recently weighed in on the stock. Goldman Sachs Group assumed coverage on shares of Metlife in a research note on Wednesday, October 18th. They set a “conviction-buy” rating and a $61.00 price objective on the stock. Langen Mcalenn restated a “buy” rating on shares of Metlife in a research note on Wednesday, August 16th. B. Riley restated a “neutral” rating on shares of Metlife in a research note on Monday, November 6th. ValuEngine lowered shares of Metlife from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 10th. Finally, Wells Fargo & Company restated a “buy” rating on shares of Metlife in a research note on Wednesday, October 18th. One analyst has rated the stock with a sell rating, nine have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $58.40.

In other Metlife news, insider Christopher G. Townsend sold 55,712 shares of the business’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $54.29, for a total value of $3,024,604.48. Following the completion of the sale, the insider now owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Christopher G. Townsend sold 82,731 shares of the business’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the completion of the sale, the insider now directly owns 49,660 shares of the company’s stock, valued at approximately $2,711,436. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://stocknewstimes.com/2017/12/14/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-metlife-met-share-price.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Insider Buying and Selling by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply